141 related articles for article (PubMed ID: 35609047)
1. Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when.
Bjorklund M; Shiely F; Gillies K
PLoS One; 2022; 17(5):e0268898. PubMed ID: 35609047
[TBL] [Abstract][Full Text] [Related]
2. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation.
Gillies K; Huang W; Skea Z; Brehaut J; Cotton S
Trials; 2014 Feb; 15():62. PubMed ID: 24548781
[TBL] [Abstract][Full Text] [Related]
3. When describing harms and benefits to potential trial participants, participant information leaflets are inadequate.
Cuddihy L; Howick J; Murphy E; Shiely F
Trials; 2024 May; 25(1):292. PubMed ID: 38693579
[TBL] [Abstract][Full Text] [Related]
4. Trial participants' self-reported understanding of randomisation phrases in participation information leaflets can be high, but acceptability of some descriptions is low, especially those linked to gambling and luck.
Shiely F; Murphy E; Gilles K; Hood K; O'Sullivan L; Harman N; Isaacs T; Treweek S
Trials; 2024 Jun; 25(1):391. PubMed ID: 38890748
[TBL] [Abstract][Full Text] [Related]
5. Patient information leaflets for placebo-controlled surgical trials: a review of current practice and recommendations for developers.
Cousins S; Huttman M; Blencowe N; Tsang C; Elliott D; Blazeby J; Beard DJ; Campbell MK; Gillies K
Trials; 2024 May; 25(1):339. PubMed ID: 38778336
[TBL] [Abstract][Full Text] [Related]
6. Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols.
Murphy E; Gillies K; Shiely F
Trials; 2024 Jun; 25(1):372. PubMed ID: 38858790
[TBL] [Abstract][Full Text] [Related]
7. Relative importance of informational items in participant information leaflets for trials: a Q-methodology approach.
Innes K; Cotton S; Campbell MK; Elliott J; Gillies K
BMJ Open; 2018 Sep; 8(9):e023303. PubMed ID: 30185580
[TBL] [Abstract][Full Text] [Related]
8. Informed consent and placebo effects: a content analysis of information leaflets to identify what clinical trial participants are told about placebos.
Bishop FL; Adams AE; Kaptchuk TJ; Lewith GT
PLoS One; 2012; 7(6):e39661. PubMed ID: 22761859
[TBL] [Abstract][Full Text] [Related]
9. Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture.
Cheon S; Park HJ; Chae Y; Lee H
BMC Med Res Methodol; 2018 Jan; 18(1):13. PubMed ID: 29347917
[TBL] [Abstract][Full Text] [Related]
10. The OMACS-PIL study: a randomised controlled trial within the OMACS observational study.
Culliford L; Brierley R; Clout M; Evans R; Maishman R; Phillips D; Tabusa H; Reeves B; Rogers CA
Trials; 2019 Dec; 20(1):772. PubMed ID: 31881927
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of instructions in patient information leaflets for the use of intranasal corticosteroid sprays: an observational study.
Rollema C; van Roon EM; Schilder AG; de Vries TW
BMJ Open; 2019 Jan; 9(1):e026710. PubMed ID: 30647049
[TBL] [Abstract][Full Text] [Related]
12. Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials.
Kirby N; Shepherd V; Howick J; Betteridge S; Hood K
Trials; 2020 Jul; 21(1):658. PubMed ID: 32680561
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Positively Framing Side-Effect Risk in Two Different Formats on Side-Effect Expectations, Informed Consent and Credibility: A Randomised Trial of 16- to 75-Year-Olds in England.
Webster RK; Rubin GJ
Drug Saf; 2020 Oct; 43(10):1011-1022. PubMed ID: 32557180
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence-generated patient information leaflets: a comparison of contents according to British Association of Dermatologists standards.
Verran C
Clin Exp Dermatol; 2024 Jun; 49(7):711-714. PubMed ID: 38169318
[TBL] [Abstract][Full Text] [Related]
15. An enhanced participant information leaflet and multimedia intervention to improve the quality of informed consent to a randomised clinical trial enrolling people living with HIV and obesity: a protocol for a Study Within A Trial (SWAT).
O'Sullivan L; Savinelli S; O'Hare S; Holden S; McHugh C; Mallon P; Doran P
Trials; 2022 Jan; 23(1):50. PubMed ID: 35039057
[TBL] [Abstract][Full Text] [Related]
16. Readability and understandability of clinical research patient information leaflets and consent forms in Ireland and the UK: a retrospective quantitative analysis.
O'Sullivan L; Sukumar P; Crowley R; McAuliffe E; Doran P
BMJ Open; 2020 Sep; 10(9):e037994. PubMed ID: 32883734
[TBL] [Abstract][Full Text] [Related]
17. Decision aids for randomised controlled trials: a qualitative exploration of stakeholders' views.
Gillies K; Skea ZC; Campbell MK
BMJ Open; 2014 Aug; 4(8):e005734. PubMed ID: 25138811
[TBL] [Abstract][Full Text] [Related]
18. Patient information leaflets for antidepressants: are patients getting the information they need?
Haw C; Stubbs J
J Affect Disord; 2011 Jan; 128(1-2):165-70. PubMed ID: 20656359
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol.
Perrenoud B; Velonaki VS; Bodenmann P; Ramelet AS
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):82-94. PubMed ID: 26571285
[TBL] [Abstract][Full Text] [Related]
20. Readability of endoscopy information leaflets: Implications for informed consent.
Mason MC; Williamson JML
Int J Clin Pract; 2018 May; 72(5):e13099. PubMed ID: 29726067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
